Subscribe To
Terns Announces Pricing of $75 Million Public Offering
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced the pricing of its underwritten public offering of 10,350,000 shares of its common […] The post Terns Announces Pricing of $75 Million Public Offering appear...
Read More
Posted: Dec 21 2022, 00:40
Author Name: forextv
Views: 103028